Aita Bio Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Aita Bio Inc. - overview
Established
2020
Location
New York, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, and founded in 2020 by its CEO Jacob Menture, Aita Bio Inc. operates as a bio-MEMS company that develops an integrated micro-electro-mechanical system (MEMS) augmented biology platform. In May 2020, Aita Bio Inc. raised USD 8.
5 million in series A funding led by new investor Hammerstone Capital with participation from other new investors Blackpoint Partners and Skyview Investment Advisors. Other unspecified investors also participated in the round. Aita Bio Inc. develops an integrated Micro-Electro-Mechanical Systems (MEMS) augmented biology platform, a process technology used to create tiny integrated devices or systems that combine mechanical and electrical components.
The company plans to use the series A funding to develop its biology platform.
Current Investors
SkyView Investment Advisors, Blackpoint Partners, Hammerstone Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Medical Software
Verticals
HealthTech
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.